What 4 Analyst Ratings Have To Say About Dolby Laboratories

Loading...
Loading...

Dolby Laboratories DLB has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 3 1 0 0 0
Last 30D 1 0 0 0 0
1M Ago 0 1 0 0 0
2M Ago 2 0 0 0 0
3M Ago 0 0 0 0 0

Insights from analysts' 12-month price targets are revealed, presenting an average target of $98.5, a high estimate of $100.00, and a low estimate of $98.00. Observing a 0.51% increase, the current average has risen from the previous average price target of $98.00.

Analyzing Analyst Ratings: A Detailed Breakdown

The perception of Dolby Laboratories by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Steven Frankel Rosenblatt Maintains Buy $98.00 $98.00
James Goss Barrington Research Announces Outperform $100.00 -
Steve Frankel Rosenblatt Maintains Buy $98.00 $98.00
Steve Frankel Rosenblatt Maintains Buy $98.00 $98.00

Key Insights:

  • Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Dolby Laboratories. This information provides a snapshot of how analysts perceive the current state of the company.
  • Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Dolby Laboratories compared to the broader market.
  • Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Dolby Laboratories's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.

Capture valuable insights into Dolby Laboratories's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.

Stay up to date on Dolby Laboratories analyst ratings.

About Dolby Laboratories

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Understanding the Numbers: Dolby Laboratories's Finances

Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.

Decline in Revenue: Over the 3 months period, Dolby Laboratories faced challenges, resulting in a decline of approximately -3.02% in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.

Net Margin: Dolby Laboratories's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 26.84%, the company showcases strong profitability and effective cost management.

Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 4.1%, the company may need to address challenges in generating satisfactory returns for shareholders.

Return on Assets (ROA): Dolby Laboratories's ROA stands out, surpassing industry averages. With an impressive ROA of 3.27%, the company demonstrates effective utilization of assets and strong financial performance.

Debt Management: Dolby Laboratories's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.02.

The Core of Analyst Ratings: What Every Investor Should Know

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...